Leptin increases IR and the production of fatty acids in hepatocytes and promotes inflammatory and fibrogenic pathways in the liver (39), mechanisms that can contribute to the development of NAFLD. This evidence concerns the gene LEP and metabolic dysfunction-associated steatotic liver disease.